Pharmaceutical companies such as Pfizer, Johnson & Johnson, Moderna, and Astra-Zeneca were actively lobbying governments to buy their vaccines as early as February 2020, supposedly less than a month after the genetic sequence (or partial sequence) was made available by China.
